摘要
目的：研究分析老年原发性高血压合并2型糖尿病患者接受缬沙坦配伍氨氯地平治疗的效果。方法2012-2014年我院共有144例老年原发性高血压合并2型糖尿病患者接受研究，我们将其分组为对照组和联合组，两组均是72例患者，对照组患者接受缬沙坦药物治疗，联合组接受缬沙坦配伍氨氯地平治疗，根据两组患者的临床效果和不良反应情况来进行对比分析。结果两组患者经过治疗后，对照组的临床有效率是79.2%，联合组的临床有效率是97.2%，其结果具有统计学差异性（P〈0.05），联合组患者的血压、血糖水平控制也比较良好，组间差异性不明显（P〈0.05）。联合组和对照组患者都没有出现严重不良反应病例，无统计学差异性（P〉0.05）。讨论老年原发性高血压合并2型糖尿病患者接受缬沙坦配伍氨氯地平治疗的临床效果比较好，总有效率高，副作用少。
Objective To analyze the effect of the treatment of senile hypertension complicated with type 2 diabetes by compatibility of valsartan and amlodipine. Methods Selected the total 144 cases of patients with senile primary hypertension complicated with type 2 diabetes in our hospital from 2012 to 2014. Divided into control group and joint group averagely. The 72 cases in control group with valsartan medication, the others in joint group with valsartan and amlodipine. Results The clinical efficiency of the control group was 79.2%,the clinical efficiency in combination group was 97.2%. There was statistically significant difference,P〈0.05. The level of blood pressure and blood sugar control of patients in joint group be controlled better. There was no difference between groups,P〈0.05. There was no serious adverse reaction in both groups. There was no statistical differences,P〉0.05. Conclusion The treatment of senile hypertension complicated with type 2 diabetes by compatibility of valsartan and amlodipine have better clinical effect, higher effective rate and less side effects. The method can be widely used in clinical.
出处
《中国卫生标准管理》
2015年第10期98-99,共2页
China Health Standard Management
